Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities

Obesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid acc...

Full description

Bibliographic Details
Main Authors: Steven Tun, Caleb James Spainhower, Cameron Lee Cottrill, Hari Vishal Lakhani, Sneha S. Pillai, Anum Dilip, Hibba Chaudhry, Joseph I. Shapiro, Komal Sodhi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01234/full
id doaj-186f95cae2814caf9136d94cf8e476f6
record_format Article
spelling doaj-186f95cae2814caf9136d94cf8e476f62020-11-25T03:52:34ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-08-011110.3389/fphar.2020.01234581131Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated ComorbiditiesSteven TunCaleb James SpainhowerCameron Lee CottrillHari Vishal LakhaniSneha S. PillaiAnum DilipHibba ChaudhryJoseph I. ShapiroKomal SodhiObesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid accumulation, however, the physiological consequences of obesity are far more concerning. The development of the obesity phenotype constitutes dramatic alterations in adipocytes, along with several other cellular mechanisms which causes substantial increase in systemic oxidative stress mediated by reactive oxygen species (ROS). These alterations promote a chronic state of inflammation in the body caused by the redox imbalance. Together, the systemic oxidative stress and chronic inflammation plays a vital role in maintaining the obese state and exacerbating onset of cardiovascular complications, Type II diabetes mellitus, dyslipidemia, non-alcoholic steatohepatitis, and other conditions where obesity has been linked as a significant risk factor. Because of the apparent role of oxidative stress in the pathogenesis of obesity, there has been a growing interest in attenuating the pro-oxidant state in obesity. Hence, this review aims to highlight the therapeutic role of antioxidants, agents that negate pro-oxidant state of cells, in ameliorating obesity and associated comorbidities. More specifically, this review will explore how various antioxidants target unique and diverse pathways to exhibit an antioxidant defense mechanism.https://www.frontiersin.org/article/10.3389/fphar.2020.01234/fullobesityoxidative stressantioxidantsadipocytescardiovascular diseasediabetes
collection DOAJ
language English
format Article
sources DOAJ
author Steven Tun
Caleb James Spainhower
Cameron Lee Cottrill
Hari Vishal Lakhani
Sneha S. Pillai
Anum Dilip
Hibba Chaudhry
Joseph I. Shapiro
Komal Sodhi
spellingShingle Steven Tun
Caleb James Spainhower
Cameron Lee Cottrill
Hari Vishal Lakhani
Sneha S. Pillai
Anum Dilip
Hibba Chaudhry
Joseph I. Shapiro
Komal Sodhi
Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
Frontiers in Pharmacology
obesity
oxidative stress
antioxidants
adipocytes
cardiovascular disease
diabetes
author_facet Steven Tun
Caleb James Spainhower
Cameron Lee Cottrill
Hari Vishal Lakhani
Sneha S. Pillai
Anum Dilip
Hibba Chaudhry
Joseph I. Shapiro
Komal Sodhi
author_sort Steven Tun
title Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
title_short Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
title_full Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
title_fullStr Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
title_full_unstemmed Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities
title_sort therapeutic efficacy of antioxidants in ameliorating obesity phenotype and associated comorbidities
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-08-01
description Obesity has been a worldwide epidemic for decades. Despite the abundant increase in knowledge regarding the etiology and pathogenesis of obesity, the prevalence continues to rise with estimates predicting considerably higher numbers by the year 2030. Obesity is characterized by an abnormal lipid accumulation, however, the physiological consequences of obesity are far more concerning. The development of the obesity phenotype constitutes dramatic alterations in adipocytes, along with several other cellular mechanisms which causes substantial increase in systemic oxidative stress mediated by reactive oxygen species (ROS). These alterations promote a chronic state of inflammation in the body caused by the redox imbalance. Together, the systemic oxidative stress and chronic inflammation plays a vital role in maintaining the obese state and exacerbating onset of cardiovascular complications, Type II diabetes mellitus, dyslipidemia, non-alcoholic steatohepatitis, and other conditions where obesity has been linked as a significant risk factor. Because of the apparent role of oxidative stress in the pathogenesis of obesity, there has been a growing interest in attenuating the pro-oxidant state in obesity. Hence, this review aims to highlight the therapeutic role of antioxidants, agents that negate pro-oxidant state of cells, in ameliorating obesity and associated comorbidities. More specifically, this review will explore how various antioxidants target unique and diverse pathways to exhibit an antioxidant defense mechanism.
topic obesity
oxidative stress
antioxidants
adipocytes
cardiovascular disease
diabetes
url https://www.frontiersin.org/article/10.3389/fphar.2020.01234/full
work_keys_str_mv AT steventun therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT calebjamesspainhower therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT cameronleecottrill therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT harivishallakhani therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT snehaspillai therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT anumdilip therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT hibbachaudhry therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT josephishapiro therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
AT komalsodhi therapeuticefficacyofantioxidantsinamelioratingobesityphenotypeandassociatedcomorbidities
_version_ 1724482102981820416